K E Wells
Overview
Explore the profile of K E Wells including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
375
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wells D, Wells K
Acta Myol
. 2006 Apr;
24(3):172-80.
PMID: 16629050
Animal models of DMD have played, and will continue to play, a key role in the understanding of the pathogenesis and treatment of Duchenne muscular dystrophy (DMD). The mdx mouse...
2.
Ferrer A, Foster H, Wells K, Dickson G, Wells D
Gene Ther
. 2004 Feb;
11(11):884-93.
PMID: 14985788
One of the possible therapies for Duchenne muscular dystrophy (DMD) is the introduction of a functional copy of the dystrophin gene into the patient. For this approach to be effective,...
3.
Wells K, Fletcher S, Mann C, Wilton S, Wells D
FEBS Lett
. 2003 Oct;
552(2-3):145-9.
PMID: 14527677
The use of antisense oligonucleotides (AOs) to induce exon skipping leading to generation of an in-frame dystrophin protein product could be of benefit in around 70% of Duchenne muscular dystrophy...
4.
Gollins H, McMahon J, Wells K, Wells D
Gene Ther
. 2003 Mar;
10(6):504-12.
PMID: 12621454
The efficiency of plasmid gene transfer in skeletal muscle is significantly enhanced by pretreatment with hyaluronidase and the application of an electrical field to the muscle following the injection of...
5.
McMahon J, Signori E, Wells K, Fazio V, Wells D
Gene Ther
. 2001 Aug;
8(16):1264-70.
PMID: 11509960
The efficiency of plasmid gene transfer to skeletal muscle can be significantly improved by the application of an electrical field to the muscle following injection of plasmid DNA. However, this...
6.
HOWELL S, Shirley M, Grese T, Neel D, Wells K, Ulm E
Drug Metab Dispos
. 2001 Jun;
29(7):990-8.
PMID: 11408365
The metabolism of bexarotene, a rexinoid recently approved in the United States for treatment of cutaneous T-cell lymphoma, was studied using liver slices from untreated rats and dogs, liver microsomes...
7.
Ferrer A, Wells K, Wells D
Gene Ther
. 2000 Sep;
7(17):1439-46.
PMID: 11001363
Introduction of dystrophin by gene transfer into the dystrophic muscles of Duchenne muscular dystrophy (DMD) patients has the possibility of triggering an immune response as many patients will not have...
8.
Kuhn A, Singh S, Smith P, Ko F, Falcone R, Lyle W, et al.
Ann Plast Surg
. 2000 Apr;
44(4):387-91.
PMID: 10783094
Periprosthetic breast capsules composed of fibrotic collagenous material with increased collagen production are not dissimilar to other fibrotic conditions occurring in other organs. Fibrosis in the lung, liver, kidney, and...
9.
Pu L, Cruse C, Wells K, Cantor A, Glass L, Messina J, et al.
Plast Reconstr Surg
. 2000 Feb;
104(4):964-9.
PMID: 10654734
Lymphatic mapping and sentinel lymph node biopsy is a new technique used in the surgical treatment of patients with malignant melanoma. The purpose of this study was to evaluate the...
10.
Wells K, Stadelmann W, Rapaport D, Hamlin R, Cruse C, Reintgen D
Ann Plast Surg
. 1999 Jul;
43(1):1-6.
PMID: 10402980
Malignant melanoma of the head and neck can metastasize to lymph nodes within the parotid gland. Selective lymphadenectomy is the modern method of staging regional lymph node basins in clinically...